New wrinkle relaxer rivals botox in major trial
NCT ID NCT06585696
Summary
This study tested a new injectable treatment, CU-20101, to see if it works as well as Botox to smooth moderate to severe frown lines between the eyebrows. Over 550 adults received either the new treatment or Botox in a blinded comparison, followed by the option for repeat treatments with the new product. The main goal was to see if the new injection was similarly effective and safe for reducing the appearance of these wrinkles.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLABELLAR FROWN LINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 200443, China
Conditions
Explore the condition pages connected to this study.